Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Daprodustat in Anemic CKD Patients
NCT01047397Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of daprodustat in anemia of chronic kidney disease (CKD-A), sponsored by GSK. Started Mar 2010; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01047397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01047397.